[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 19, Issue 1 (Spring 2022) ::
Sci J Iran Blood Transfus Organ 2022, 19(1): 44-51 Back to browse issues page
Evaluation of complications of ABO incompatibility following blood transfusion in 2019
L. Kasraian, Z. Afsar, B. Shirazi, M. Farahangiz, N. Naderi
Keywords: ABO Blood-Group System, Blood Transfusion, Complications
Full-Text [PDF 292 kb]   (108 Downloads)     |   Abstract (HTML)  (453 Views)
Type of Study: Research | Subject: Blood Transfusion
Published: 2022/03/30
Full-Text:   (421 Views)
  1. Janatpour KA, Kalmin ND, Jensen HM, Holland PV. Clinical outcomes of ABO-incompatible RBC transfusions. Am J Clin Pathol 2008; 129(2): 276-81.
  2. Dzik WH. New technology for transfusion safety. Br J Haematol 2007; 136(2): 181-90.
  3. Kasraian L, Karimi MH. The Incidence rate of acute transfusion reactions in thalassemia patients referred to the Shiraz Thalassemia Centre, Shiraz, Iran, before and after the establishment of the hemovigilance system. Hemoglobin 2015; 39(4): 274-80.
  4. Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006; 20(4): 273-82.
  5. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990; 30(7): 583-90.
  6. Mardani A, Balali MR. Transfusion reactions: A retrospective analysis of the Iranian national haemovigilance system (INHS) data. Transfus Apher Sci 2020; 59(4): 102767.
  7. Kasraian L, Tavassoli A. Transfusion related non-infectious complications: implications for an appropriate reporting (hemovigilance) system. J Appl Hematol 2010; 1(1): 47.
  8. Nuttall GA, Stubbs JR, Oliver Jr WC. Transfusion errors: causes, incidence, and strategies for prevention. Curr Opin Anaesthesiol 2014; 27(6): 657-9.
  9. Stainsby D, Russell J, Cohen H, Lilleyman J. Reducing adverse events in blood transfusion. Br J Haematol 2005; 131(1): 8-12.
  10. Dhabangi, A. Transfusion in sub-Saharan Africa: Blood products, clinical care and community perceptions; 2019. Avalable from: https://pure.uva.nl/ws/files/39939406/Thesis_complete_.pdf
  11. Bolton-Maggs P. Serious hazards of transfusion-conference report: celebration of 20 years of UK haemovigilance. Transfus Med 2017; 27(6): 393-400.
  12. Dzik WS, Beckman N, Selleng K, Heddle N, Szczepiorkowski Z, Wendel S, et al. Errors in patient specimen collection: application of statistical process control. Transfusion 2008; 48(10): 2143-51.
  13. Nigam PK. Preanalytical errors: some common errors in blood specimen collection for routine investigations in hospital patients. Journal of Clinical and Diagnostic Research 2011; 5(3): 659-61.
  14. Sandhu P, Bandyopadhyay K, Ernst DJ, Hunt W, Taylor Jr TH, Birch R, et al. Effectiveness of laboratory practices to reducing patient misidentification due to specimen labeling errors at the time of specimen collection in healthcare settings: LMBP™ systematic review. J Appl Lab Med 2017; 2(2): 244-58.
  15. Linden J, Paul B, Dressler K. A report of 104 transfusion errors in New York State. Transfusion 1992; 32(7): 601-6.
  16. Gilliss BM, Looney MR, Gropper MA, Warner DS. Reducing noninfectious risks of blood transfusion. Anesthesiology 2011; 115(3): 635-49.
  17. Franchini M. Errors in transfusion: causes and measures to avoid them. Clin Chem Lab Med 2010; 48(8): 1075-7.
  18. Sahu S, Hemlata AV. Adverse events related to blood transfusion. Indian J Anaesth 2014; 58(5): 543-51.
  19. Linden JV, Wagner K, Voytovich AE, Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion 2000; 40(10): 1207-13.
  20. Short R. Poor checks for bedside blood transfusion put patients at risk. BMJ 2006; 332(7551): 1171. 

Sci J Iran Blood Transfus Organ 2022;19 (1): 44-51
Original Article

Evaluation of complications of ABO incompatibility
following blood transfusion in 2019

Kasraian L.1,2, Afsar Z.3, Shirazi B.3, Farahangiz M.3, Naderi N.3,4

1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2Shiraz Blood Transfusion Center, Shiraz, Iran
3Shiraz University of Medical Sciences, Shiraz, Iran
4Shiraz Anesthesiology and Critical Care Research Center. Shiraz, Iran

Background and Objectives
One of the dangers of blood transfusions is the mistakes that lead to the wrong blood transfusion to the patient. This study was performed to identify the types of errors that lead to incompatible transfusions to prevent their recurrence and increase recipients health.

Materials and Methods
This cross-sectional study was performed on complications of ABO incompatibility caused by transfusion in 2019 in Shiraz hospitals. Demographic characteristics of blood recipients (age, sex, diagnosis, history of transfusion, blood type), type of product received, blood type of product received, incompatible blood volume injected, symptoms and causes of ABO incompatibility were determined. Chi-square and t-test were used to analyze data.

A total of 9 complications of ABO incompatibility were reported; 7 cases (77.8%) were due to packed red blood cells, one case (11.1%) due to platelet injection and one (11.1%) due to plasma injection. Seven cases occurred in patients undergoing surgery, one case in neonates and one in thalassemia patients. In terms of clinical symptoms, only one patient developed chills. The rest of the patients had no symptoms. The most common error leading to inconsistency was the lack of accurate identification in 6 cases (66.7%) and in 2 cases (22.2%) sampling error and in one (11.1%) incorrect group writing.

It seems that in order to promote safe blood transfusion, it is important to investigate the occurrence of ABO incompatibilities in order to identify blood transfusion chain errors in order to identify the causes of errors and prevent the recurrence of these complications.

Key words: ABO Blood-Group System, Blood Transfusion, Complications

Received:  20 Sep 2021
Accepted: 24 Jan 2022

Correspondence: Naderi N. Assistant Professor of Anesthesiology and Critical Care of Shiraz Anesthesiology and Critical Care Research Center. Shiraz University of Medical Sciences.
Postal code: 7195864877, Shiraz, Iran. Tel: (+9871) 36287001; Fax: (+9871) 36264006
1- Acridine Orange
1- Biological safety cabinet
1- Platelet Concentrate
2- Food and Drug Administration
3- Normal Skin Flora
4- Platelet Rich Plasma-Platelet Concentrate
5- Eosin-Methylene blue
6- Thioglycolate

Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kasraian L, Afsar Z, Shirazi B, Farahangiz M, Naderi N. Evaluation of complications of ABO incompatibility following blood transfusion in 2019. Sci J Iran Blood Transfus Organ. 2022; 19 (1) :44-51
URL: http://bloodjournal.ir/article-1-1425-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 19, Issue 1 (Spring 2022) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 4419